Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Clinical Endocrinology|June 26, 2001
An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settingsH Kumar, J Daykin, R Holder, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 4, 2003
External beam radiotherapy in the management of differentiated thyroid cancerD Ford, S Giridharan, C McConkey, et al.
Expert Opinion on Drug Delivery|December 10, 2015
Future of the transdermal drug delivery market--have we barely touched the surface?Adam C Watkinson, Mary-Carmel Kearney, Helen L Quinn, et al.
Thyroid : Official Journal of the American Thyroid Association|December 14, 1999
Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytologyH Kumar, J Daykin, R Holder, et al.
Clinical Otolaryngology and Allied Sciences|October 1, 1990
The reliability of palpation in the assessment of tumoursJ C Watkinson, D Johnston, N Jones, et al.
The Journal of Laryngology and Otology|October 1, 1990
Technetium-99m(v) dimercaptosuccinic acid planar scintigraphy in head and neck cancer: clinical, scintigraphic and radiological studyJ C Watkinson, C E Todd, C R Lazarus, et al.
Clinical Otolaryngology and Allied Sciences|December 1, 1990
Technetium-99m (v) dimercaptosuccinic acid: a clinical and scintigraphic study in an animal tumour modelJ C Watkinson, S Allen, C R Lazarus, et al.
Annals of the Royal College of Surgeons of England|January 1, 1991
Experience in the surgical management of medullary thyroid carcinomaF J Lannigan, J C Watkinson, S E Clarke, et al.
The Journal of Clinical Endocrinology and Metabolism|July 27, 2006
Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspirationK Boelaert, J Horacek, R L Holder, et al.
Endocrinology|April 9, 2005
Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signalingJames D Ramsden, Malcolm A Buchanan, Stuart Egginton, et al.
Pageof 12